logo
Gold, debt and stocks: Why multi-asset funds are the smartest play

Gold, debt and stocks: Why multi-asset funds are the smartest play

Economic Times10-05-2025

So, What Exactly Is a Multi-Asset Allocation Fund?
Live Events
Why Is This Category Becoming More Popular in 2025?
1. Equities Are Volatile, Not Cheap
2. Debt Has Stabilised, But Yields Are Capped
3. Gold Is Quietly Doing Its Job
4. The New Investing Generation Wants Simplicity
How Much Do These Funds Allocate?
Equity allocations in MAAFs range from just over 20% (for conservative models) to 70% or more (for aggressive growth strategies).
Debt allocations vary just as much — from under 10% in some funds to over 50% in others.
Gold or alternative assets (like international equity or REITs) often make up 5–20%, depending on the fund's objective.
What About Tax Efficiency?
Are There Risks?
Manager's skill matters: In dynamically allocated funds, poor asset calls can hurt performance. The fund's success depends on how well the managers read macro signals.
Asset class caps: Some funds may be constrained by internal rules or SEBI mandates, limiting flexibility.
Lag in aggressive markets: In a bull run, a MAAF may underperform a 100% equity fund, simply because it's holding debt or gold for protection.
What Makes a Good MAAF?
Have a clear asset allocation framework (and communicate it transparently)
Show a track record of navigating both bull and bear markets
Include exposure to non-traditional assets (like global equities or REITs) for added diversification
Deliver consistency, even if not the highest headline returns
Final Thoughts: Balance is the New Alpha
In 2025, Indian investors are standing at an inflexion point. Equity valuations are running high, debt yields have started to flatten, and gold is no longer just a cultural asset — it's a strategic one. In this environment, the conventional wisdom of 'just stay in equities' is being challenged. And a quiet category of mutual funds — multi-asset allocation funds (MAAFs) — is starting to shine.These are not the flashy, high-return funds that dominate social media. But for investors who care about stability, resilience, and a smoother investing experience, multi-asset allocation funds may be one of the smartest decisions in today's cycle.Put simply, it's a mutual fund that spreads your money across at least three different asset classes — typically equity, debt, and gold. Some mutual funds even extend their reach by providing exposure to international equities, REITs (Real Estate Investment Trusts), or InvITs (Infrastructure Investment Trusts).Think of it as a pre-assembled portfolio managed by professionals. Instead of juggling different funds for equity growth, debt stability, and gold protection, a MAAF wraps them all into one. That means fewer decisions, less panic during market dips, and a built-in diversification engine.The rise of MAAFs isn't random. It's being driven by a combination of market volatility, macro uncertainty, and maturing investor behavior.Indian equity markets have delivered handsome returns over the past few years. But valuations have reached multi-year highs in several sectors. That doesn't mean a crash is coming, but it does suggest that the next few years might see slower, bumpier growth.After a period of rising interest rates, most debt instruments have stabilised. Yields are no longer falling, but they're not expected to rise significantly either. Debt, therefore, becomes a useful anchor — it adds predictability without dragging too much on returns.Gold has done what it always does in times of macro uncertainty — protect capital. With geopolitical risks, shifting interest rate policies in the West, and inflation still a concern, gold adds a meaningful hedge against sharp equity corrections.Today's investors are not just looking for alpha (market-beating returns) — they're looking for clarity, peace of mind, and consistency. MAAFs simplify portfolio management and reduce decision fatigue, especially for those who are just starting or want to automate their investing journey.The point is: no two MAAFs are alike. Their design depends on the fund house's philosophy, the target risk level, and the market outlook.Here's a lesser-known advantage: you don't pay capital gains tax when the fund switches between asset classes internally.If an investor manually switches between, say, a debt fund and a gold ETF, each move triggers a taxable event. However, in a Mutual Asset Allocation Fund (MAAF), the fund manages this rebalancing, which doesn't impact the investor's tax bill unless they sell the entire fund.This makes MAAFs more efficient for long-term investors who want asset allocation without tax leakage every time markets shift.Yes — but they're manageable and largely known.But these are trade-offs for a smoother ride — and often, that's precisely what investors want today.There's no one-size-fits-all answer. But a solid MAAF will typically:In an era of algorithmic trades, viral stock picks, and economic headwinds, the idea of 'playing it safe' has often been dismissed as boring. But in 2025, boring looks brilliant.Multi-asset allocation funds aren't about chasing the next 30% return. They're about reducing regret, managing risk, and staying invested without second-guessing every market turn. For long-term wealth building, that's often the difference between good plans and great outcomes.These funds may not make you rich overnight, but they could make you a more confident investor over time. And that might just be the smartest investment you make this year.The author Chakravarthy V. is Cofounder & Executive Director, Prime Wealth Finserv. Views are own): Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

KKR-backed IVI to buy ART Fertility Clinics for $450 million
KKR-backed IVI to buy ART Fertility Clinics for $450 million

Economic Times

time18 minutes ago

  • Economic Times

KKR-backed IVI to buy ART Fertility Clinics for $450 million

Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with the matter. The acquisition marks a significant step in IVI RMA's global expansion, adding India to its presence in over 15 countries and more than 190 clinical offices across the US, Europe and Latin parties are in the final stages of documentation for a shareholders' agreement and are hoping to wrap up the transaction by June with private hospitals, the IVF industry in India too is witnessing consolidation as several private equity funds have been aggressive with acquisitions. In 2023, Swedish fund EQT Partners acquired a significant majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, at a $1.1 billion ('9,000 crore) Fertility Clinics began in 2015 as IVI Middle East, an international arm of IVI RMA Global. In 2020, IVI RMA divested the business to Gulf Capital, which rebranded it as ART Fertility Clinics. Since then, the brand has rapidly grown, expanding across West Asia and clinics in Abu Dhabi, Dubai and Al Ain in the UAE as well as 11 centres across India, ART Fertility has established itself as a high-performance network in reproductive medicine. The Indian expansion began in 2021, backed by a $30 million investment from Gulf Fertility operates in big Indian cities including Mumbai, Noida, Ahmedabad, Chennai, Hyderabad, Gurgaon and by Suresh Soni, former co-founder and CEO of Nova IVF Fertility, ART Fertility reports a pregnancy success rate of 70% and has recorded over 5,000 successful pregnancies in under nine to sources, ART Fertility posted revenue of $100-120 million in FY25, with an estimated Ebitda of $35 million."For an Indian healthcare player, a $25-35 million ebitda which is borderline ebitda positive coming from the Middle East would add no value," said a fund manager at a Mumbai-based private equity firm that operates a pan-India IVF chain. "However, IVI being a US player where multiples are low, adding a Middle East business works well."IVI RMA trumped a rival bid by Temasek-backed Cloudnine Hospitals.A KKR spokesperson declined to comment. IVI RMA and ART Fertility did not respond to is the advisor in the is rapidly emerging as one of the world's fastest-growing markets for Assisted Reproductive Technology (ART). However, the sector has scope for expansion at 210 IVF cycles per million people, compared with 1,200 in the US and over 2,000 in affects approximately 15% of Indian couples, a figure expected to rise due to lifestyle factors such as poor diet, stress, late marriages, and to EY, India's IVF market is expected to grow from $793 million in 2020 to $1.45 billion by 2027, at a projected CAGR of 15-20%.India sees around 300,000 IVF cycles annually, with projections suggesting this could grow to 500,000-600,000 cycles by 2030. About 30% of the market is controlled by 10-15 organised players, while the remaining is fragmented among smaller, unorganised clinics. Key players in India's fertility sector include Indira IVF, Nova IVF, Oasis IVF, Bloom Fertility Centre, Bengaluru-based Milann, Morpheus IVF, Ridge IVF, Akanksha IVF and Bourn Hall IVF, the second largest player in India, is owned by Asia Healthcare Holdings (AHH), the single specialty hospitals platform backed by GIC and homegrown PE fund Kedaara Capital owns a minority stake in Oasis Fertility, while Brussels-based fund Verlinvest owns a controlling stake in Ferty9 F, a premier chain of fertility clinics in the AP/Telangana region.

Carpet area of new flats in Mumbai 43% less than super built-up — biggest gap in country
Carpet area of new flats in Mumbai 43% less than super built-up — biggest gap in country

Time of India

timean hour ago

  • Time of India

Carpet area of new flats in Mumbai 43% less than super built-up — biggest gap in country

Mumbai: Apartments in the Mumbai Metropolitan Region (MMR) have the highest 'loading' factor — difference between super-built-up area and carpet area — among the top seven Indian cities. Tired of too many ads? go ad free now According to data collated by ANAROCK Research, MMR has a loading factor of 43%. As an example, a 1,000 sq ft flat will have a living area of under 600 sq ft. "Earlier, super built-up areas were the norm for quoting and marketing, which often overstated the liveable space. While the conversation around square footage continues in the sales room across the table, the focus in advertising appears to have shifted from actual flat sizes, which was more prevalent in earlier years, to taglines such as 'spacious 2 BHK' in advertisements and on hoardings,'' said Prashant Thakur, Regional Director & Head - Research & Advisory, ANAROCK Group. "RERA mandates that all mentions of size must be only based on carpet area. This is strictly mandated in Maharashtra, so marketing has had to adapt to steering the messaging around features and amenities instead. Buyers have become more conscious of shrinking liveable spaces and rising loading percentages," he added. Amid the rising demand for state-of-the-art amenities within housing projects, the 'loading' factor has been on the rise across the top cities. MMR continues to see the highest loading— difference between super-built-up area and carpet area— among the top 7 cities with 43% in Q1 2025. The region has seen the average loading percentage grow steadily over the years —from 33% in 2019 to 39% in 2022, and 43% in Q1 2025. Bengaluru has seen the highest percentile jump in average loading over the last seven years, from 30% in 2019 to 41% in Q1 2025. In 2022, it was 35%. This dovetails with the increasingly higher saturation of modern amenities that developers now include to cater to the higher lifestyle ask in the IT hub. Tired of too many ads? go ad free now Chennai, on the other hand, has the least average loading rise in Q1 2025 with 36%, aligning with a city-specific demand profile where homebuyers prefer to pay more for usable space within their homes rather than for common areas. In 2019, Chennai's average loading percentage was 30%, like Bengaluru. It gradually rose to 32% in 2022 and further to 36% in Q1 2025. In NCR, average loading percentage rose from 31% in 2019 to 37% in 2022, and 41% in Q1 2025. In Pune, it was 32% in 2019, rose to 36% in 2022, and stood at 40% in Q1 2025. Hyderabad saw an average loading percentage increase from 30% in 2019 to 33% in 2022, and to 38% in Q1 2025. Kolkata too saw its average loading factor increase from 30% in 2019 to 35% in 2022, and further to 39% in Q1 2025. "While RERA now requires developers to mention the total carpet area provided to homebuyers, no law currently limits the loading factor in projects. Q1 2025 readings show that 60% of total space within their apartment that homebuyers in the top seven cities pay for is livable space, the remaining 40% is common areas – elevators, lobbies, staircases, clubhouses, amenities, terraces, and so on. The average loading percentage was 31% back in 2019," said Thakur. "Today, higher amenity loading has become the norm across most projects, partly because homebuyers are no longer satisfied with basic lifestyle amenities - they expect fitness centres, clubhouses, park-like gardens, and grand lobbies. Collectively, these features may improve comfort, community livability, and also resale value; however, homebuyers effectively lose on actual usable space within their apartments, " he said. Essential infrastructure in modern housing projects now typically includes more lifts with bigger passenger capacities, amplified utility areas, and fire escapes that meet regulatory safety protocols. In high-density urban developments, optimizing space for both private and shared use is crucial for a better living experience and long-term value, making some level of extra loading an inescapable fact of life. "Respective state RERAs should ideally enforce provisions wherein each project clearly mentions how much buyers are paying for the total usable space within the apartment, and for the amenities," the ANAROCK report said.

KKR-backed IVI to buy ART Fertility Clinics for $450 million
KKR-backed IVI to buy ART Fertility Clinics for $450 million

Time of India

timean hour ago

  • Time of India

KKR-backed IVI to buy ART Fertility Clinics for $450 million

KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with the matter. The acquisition marks a significant step in IVI RMA's global expansion, adding India to its presence in over 15 countries and more than 190 clinical offices across the US, Europe and Latin America. Both parties are in the final stages of documentation for a shareholders' agreement and are hoping to wrap up the transaction by June end. As with private hospitals, the IVF industry in India too is witnessing consolidation as several private equity funds have been aggressive with acquisitions. In 2023, Swedish fund EQT Partners acquired a significant majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, at a $1.1 billion ('9,000 crore) valuation. ART Fertility Clinics began in 2015 as IVI Middle East, an international arm of IVI RMA Global. In 2020, IVI RMA divested the business to Gulf Capital, which rebranded it as ART Fertility Clinics. Since then, the brand has rapidly grown, expanding across West Asia and India. Live Events With clinics in Abu Dhabi, Dubai and Al Ain in the UAE as well as 11 centres across India, ART Fertility has established itself as a high-performance network in reproductive medicine. The Indian expansion began in 2021, backed by a $30 million investment from Gulf Capital. ART Fertility operates in big Indian cities including Mumbai, Noida, Ahmedabad, Chennai, Hyderabad, Gurgaon and Faridabad. Led by Suresh Soni, former co-founder and CEO of Nova IVF Fertility, ART Fertility reports a pregnancy success rate of 70% and has recorded over 5,000 successful pregnancies in under nine years. According to sources, ART Fertility posted revenue of $100-120 million in FY25, with an estimated Ebitda of $35 million. "For an Indian healthcare player, a $25-35 million ebitda which is borderline ebitda positive coming from the Middle East would add no value," said a fund manager at a Mumbai-based private equity firm that operates a pan-India IVF chain. "However, IVI being a US player where multiples are low, adding a Middle East business works well." IVI RMA trumped a rival bid by Temasek-backed Cloudnine Hospitals. A KKR spokesperson declined to comment. IVI RMA and ART Fertility did not respond to queries. Moelis is the advisor in the transaction. India is rapidly emerging as one of the world's fastest-growing markets for Assisted Reproductive Technology (ART). However, the sector has scope for expansion at 210 IVF cycles per million people, compared with 1,200 in the US and over 2,000 in Europe. Infertility affects approximately 15% of Indian couples, a figure expected to rise due to lifestyle factors such as poor diet, stress, late marriages, and pollution. According to EY, India's IVF market is expected to grow from $793 million in 2020 to $1.45 billion by 2027, at a projected CAGR of 15-20%. India sees around 300,000 IVF cycles annually, with projections suggesting this could grow to 500,000-600,000 cycles by 2030. About 30% of the market is controlled by 10-15 organised players, while the remaining is fragmented among smaller, unorganised clinics. Key players in India's fertility sector include Indira IVF, Nova IVF, Oasis IVF, Bloom Fertility Centre, Bengaluru-based Milann, Morpheus IVF, Ridge IVF, Akanksha IVF and Bourn Hall Clinic. Nova IVF, the second largest player in India, is owned by Asia Healthcare Holdings (AHH), the single specialty hospitals platform backed by GIC and TPG. Similarly, homegrown PE fund Kedaara Capital owns a minority stake in Oasis Fertility, while Brussels-based fund Verlinvest owns a controlling stake in Ferty9 F, a premier chain of fertility clinics in the AP/Telangana region.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store